Miso Clinic · Clinical column

Rejuran Eye in Daegu: what’s different around the eyes? — What a thin formulation can and can’t do

“Should I have Rejuran Eye for around my eyes?” We hear this often in the consulting room. From the name alone it sounds like a dedicated treatment designed for the eyes. But I couldn’t find a clinical trial carried out under the product name. So I have separated what we know from what we don’t.

Clinical column About 7 min November 2026 Miso Clinic, Daegu · Dr. Lee Chi-Hak, Medical Director

The short answer

Rejuran Eye is a PN (polynucleotide) injection made with lower viscosity than regular Rejuran Healer so it spreads well. At launch the manufacturer described it as suited to thin skin, and it targets fine lines and thinned texture around the eyes. It doesn’t fill under-eye hollows. Broadening to other PN products, in a 27-person randomised split-face trial around the eyes, overall improvement scores did not differ from non-crosslinked hyaluronic acid, while PN did better on roughness and pores. But we couldn’t confirm a clinical trial under the Rejuran Eye product name. Miso Clinic in Daegu (4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, +82-53-428-2700) first separates whether the concern is texture, hollowing or colour, and considers Rejuran Eye for the eye area alongside.

How is Rejuran Eye different from regular Rejuran?

The starting point is the formulation. In 2016 launch coverage, the manufacturer explained that Rejuran Eye has lower viscosity than the existing Rejuran Healer and spreads well, suiting thin skin. The main ingredient is the same type, salmon-derived PN.

Differences between Rejuran names — what has been confirmed
NameComposition or featureNotes
Rejuran HealerPN aloneWhen texture · dermal density is the main goal
Rejuran HBPN + hyaluronic acidSofter formulation, with moisture right after
Rejuran HB PLUSPN + hyaluronic acid + lidocaineAnaesthetic added to reduce pain
Rejuran EyePN type, low viscosity and spreads well (manufacturer’s description)Concentration · additives not confirmed in published material

Let me clear up one misunderstanding here. The name Eye means it was designed for the eye area, not that eye-area results have been proven better. I couldn’t find a trial comparing it head to head with regular Rejuran around the eyes.

If you only want the difference between names, Rejuran Healer · HB · HB PLUS · Eye: the differences is shorter.

Which eye-area concerns does it suit?

Before choosing a product, we separate the concern. The single sentence “my eye area looks old” mixes completely different problems. Rejuran Eye only comes to my mind for the first row.

Eye-area concerns and where Rejuran Eye fits
ConcernWhat it looks likeRejuran Eye?
Fine lines · thin textureFine lines that stay without smiling, dullnessA candidate
Lines that deepen when smilingCrow’s feet that deepen with expressionNot the main treatment. That is for botulinum toxin
Under-eye hollows · tear troughA shadow that changes with the direction of lightCan’t fill it. That calls for hyaluronic acid filler placed deep
Dark circlesBrown · blue · mixed colourDepends on the cause. We don’t say it solves it alone
Protruding under-eye fatFat bulging outNot suitable. We also discuss a surgical consultation

In clinic we look both sitting and lying down, and shine light from several directions. Shadows change with posture and light; pigment doesn’t.

Eye-area Rejuran: how far does the evidence go?

To be honest, eye-area PN evidence is still thin. Moreover, the studies below are not Rejuran Eye product studies. Please read them only as data on the same category.

Eye-area PN studies — what they looked at and how
StudyDesignFindingsLimitations
Lee YJ 202027 Korean patients, randomised double-blind split face, PN vs non-crosslinked hyaluronic acid, three sessions 2 weeks apartNo difference in overall improvement score. Improvement rates for roughness · pores higher with PNSmall numbers; comparator not placebo
Kim JH 202230 Korean crow’s-feet patients enrolled · 28 completed, 18 weeksImprovement in wrinkle grade and 3D-camera wrinkles · texture · pores; no change in melaninNo control group
Ziade 2026Under-eye observation in 42 people, 2 mL per session, a different PN productQuestionnaire scores improved to 6 months, peaking 3 months after two sessionsNo control group, self-reported questionnaire
Amado 2026Dark-circle observation in 61 people, three sessions 2–3 weeks apart, a different trout-derived PNPhoto analysis showed a shift towards lighter colourNo control group, different product

Two 2026 reviews say something similar. Results are consistently good for dermal elasticity · hydration · fine lines, but study designs and formulations vary so much that nothing can be concluded (Khan 2026). Another said data are insufficient to say how much better it is compared with other treatments (Martucci 2026).

There was also a 218-person randomised trial for crow’s feet using Rejuran as the comparator, but it was retracted in 2026, on the grounds that another material used had been mislabelled. So I don’t use this trial’s numbers.

So in clinic I say this: texture may improve. But there is no number to promise how much.

Can Rejuran Eye help under-eye hollows or dark circles?

Not hollowing. PN is not a volume-filling material, so it can’t fill the shadow of a groove. For tear troughs we look first at placing hyaluronic acid filler deep. A 2025 systematic review of 50 studies also placed filler for volume loss and PN for texture and fine lines (Beer 2025).

Dark circles are a little more complicated. In a study that classified 65 people using ultrasound as well, more than three in four (78%) had mixed causes. In the 61-person study in the table above, colour did shift lighter, but there was no control group and the product was different. I don’t recommend it as a dark-circle treatment on these numbers alone.

If pigment is the main cause, injections won’t resolve it. Miso Clinic has no melasma laser, so in that case we tell you so and guide you to another option.

Why look for a thin formulation around the eyes?

It is because of thickness. In a study measuring 31 people with 33 MHz ultrasound, the lower-eyelid dermis averaged 0.53 mm, and the temples and posterior cheek 1.18 mm (Kim 2025). More than double.

With this little margin, the same amount shows through more at the surface. What didn’t show on the cheeks shows around the eyes. So even when treating the whole face, the eye-area amount is not what is left over but is reduced from the start.

That is also why a spreading formulation theoretically suits it. But it is theory. We couldn’t confirm a comparative study measuring how much less clumping or show-through there actually is. I think the depth and amount injected decide the result as much as the product name, perhaps more.

How many sessions of eye-area Rejuran, and how far apart?

Miso Clinic recommends Rejuran as one course of 3–4 sessions 3–4 weeks apart. After the course, we go by condition rather than the calendar and add one session at a time when the skin becomes dry and rough again.

In a survey of 235 Korean dermatologists, PN was most often recommended as three sessions 4 weeks apart, and dividing it into the dermis with a 33G needle was common (Rho 2023). Being a survey, it only shows practice. Intervals between studies also varied from 2 weeks (Lee 2020) to 2–3 weeks (Amado 2026).

We couldn’t confirm a trial comparing sessions or intervals for Rejuran Eye alone. So we say we start with the same framework as regular Rejuran and adjust after seeing the eye-area response to the first session.

How is the eye area after treatment? When should I contact you?

On the day, the injection points rise up plumply. These are called papules; the swelling forms because the product pools in the dermis, and they usually settle in a day or two. Your face that day is not the result. If you have a big appointment, tell us the schedule first.

No serious adverse events were reported in the eye-area trial (Lee 2020). But at 27 people, it can’t screen out rare events. We also couldn’t confirm data on the frequency of bruising · swelling with Rejuran Eye.

For these, don’t count the days — contact us straight away.

  • Severe pain during or right after injection, or pain worsening on one side only
  • When the skin turns white or purplish
  • When vision becomes blurred or abnormal
  • Swelling with redness · heat · tenderness

Are there cases where Rejuran Eye isn’t recommended?

Yes. In these cases I don’t recommend it straight away.

  • When under-eye hollowing is the main concern — the shadow may stay however many sessions you have
  • When under-eye fat bulges out — a surgical consultation comes before injections
  • When drooping eyelids are the main problem — PN is not a material that lifts sagging skin
  • During pregnancy · breastfeeding — we suggest another time
  • With active infection or inflammation at the treatment area — we look after it settles
  • When you recently had another booster — we space them out. If they overlap on the same day, we can’t tell which caused a reaction

If you take blood thinners, just let us know — don’t stop them on your own. You may bruise a little more.

If you have had something around the eyes before, tell us the product and timing too. If you don’t remember, looking up the records where you had it makes the design much easier.

Rejuran Eye in Daegu: frequently asked questions

How is Rejuran Eye different from regular Rejuran?

It is a PN injection the manufacturer described as having lower viscosity and spreading better than regular Rejuran Healer, suiting thin skin. But we couldn’t confirm a clinical trial comparing it head to head with regular Rejuran around the eyes.

Where around the eyes is Rejuran Eye used?

It targets fine lines and thinned texture around the eyes. It can’t fill under-eye hollows, and lines that deepen when smiling are for botulinum toxin.

Does Rejuran Eye improve under-eye hollows too?

PN is not a volume-filling material, so it can’t fill the shadow of a groove. For tear troughs we look first at placing hyaluronic acid filler deep.

Does it work on dark circles?

In a 61-person observational study of another PN product, colour shifted lighter, but there was no control group. Causes are often mixed, so we don’t say Rejuran Eye alone solves it.

How many sessions of Rejuran Eye do I need?

Miso Clinic recommends Rejuran as one course of 3–4 sessions 3–4 weeks apart, then adds one session at a time by condition. We couldn’t confirm a trial comparing sessions for Rejuran Eye alone.

How long does it show after treatment?

The plump papules at injection points usually settle in a day or two. If bruising occurs it may last longer. For severe pain, skin colour change or visual disturbance, don’t count the days — contact us straight away.

Where can I get an eye-area Rejuran consultation in Daegu?

Miso Clinic in Daegu is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82-53-428-2700; weekdays 11:00–19:00 · Saturday 10:00–16:00 (no lunch break); closed Sundays · public holidays.

Clinical columns to read next

Product reference

Clinic

This column was written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu. The treatment criteria and injection design are written exactly as we actually use them.

Miso Clinic
Medical DirectorLee Chi-Hak, MD
Address4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu (Exit 1, Kyungpook National University Hospital Station) · tower parking in the building
Phone053-428-2700
KakaoTalk consultationMiso Clinic Daegu channel
KakaoTalk channelAdd the channel
Opening hoursWeekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays
Clinical columnSee all columns
Reference libraryAll booster and lifting device references

References

  1. Rejuran Eye launch coverage — Dailypharm, “Pharma Research launches new skin-aesthetic injection,” 2016-09-20 (dailypharm.com/user/news/108623). Manufacturer’s description: lower viscosity than Rejuran Healer, spreads well, suitable for thin skin. A report relaying the company’s description, not clinical comparative data.
  2. Randomised trial of PN vs non-crosslinked hyaluronic acid around the eyes — Lee YJ et al., J Dermatolog Treat 2022;33(1):254–260 (online 2020), PMID 32248707, DOI 10.1080/09546634.2020.1748857. 27 people, double-blind split face, three sessions 2 weeks apart. No difference in VAS · GAIS; higher improvement rates in roughness · pore volume with PN; no difference in dermal density; no serious adverse events.
  3. 3D measurement of PN for crow’s feet — Kim JH et al., Aesthetic Plast Surg 2022;46(4):1902–1909, PMID 35357558, DOI 10.1007/s00266-022-02832-8. 30 enrolled · 28 completed, 18 weeks. Wrinkle grade p<0.001, wrinkles · texture · pores p<0.05, no change in melanin. No control group.
  4. Prospective under-eye PN observation — Ziade G et al., J Cosmet Dermatol 2026;25(2):e70736, PMID 41689167, DOI 10.1111/jocd.70736. 42 people, a different PN product at 7.5 mg/mL, 2 mL per session. FACE-Q scores improved at 1 · 3 · 6 months, peaking 3 months after two sessions. No control group.
  5. Real-world study of PN for dark circles — Amado et al., Clin Cosmet Investig Dermatol 2026;19:605046, PMID 42164086, DOI 10.2147/CCID.S605046. Multicentre observation of 61 people, trout-derived PN 7.5 mg/mL, three sessions 2–3 weeks apart. Photo analysis showed a shift towards lighter colour (p<0.001). No control group.
  6. Review of HA vs PN under the eyes — Khan, Hafeez, J Clin Med 2026;15(13):4971, PMID 42452433, DOI 10.3390/jcm15134971. HA for structural correction, PN for dermal quality; differences in design · formulation prevent firm conclusions.
  7. Periorbital rejuvenation review — Martucci et al., Front Med 2026;13:1943441, PMID 42936325, DOI 10.3389/fmed.2026.1943441. Early data on PN · collagen stimulators are positive, but evidence is insufficient to establish comparative efficacy.
  8. Systematic review of under-eye treatments — Beer et al., Dermatol Surg 2026;52(2):155–163 (online 2025), PMID 41615388, DOI 10.1097/DSS.0000000000004964. 50 studies. Filler for volume loss, PN for texture · fine lines, surgery for protruding fat · reduced lower-eyelid support.
  9. Dermal thickness by facial area — Kim et al., Plast Reconstr Surg Glob Open 2025;13(9):e7121, PMID 41000432, DOI 10.1097/GOX.0000000000007121. 31 people, 33 MHz ultrasound. Lower eyelid 0.53 mm to temples · posterior cheek 1.18 mm.
  10. Survey of PN use by Korean dermatologists — Rho NK et al., J Cosmet Dermatol 2024;23(4):1243–1252, PMID 38093498, DOI 10.1111/jocd.16125. 235 doctors; under-eye · periorbital fine lines as major indications; 33G serial dermal injection; three sessions 4 weeks apart.
  11. Retracted trial — not used — Choi SY et al., J Cosmet Dermatol 2025;24(1):e16576, PMID 39313949. 218 crow’s-feet patients, PCL vs Rejuran. Retracted in 2026 (retraction notice PMID 41834780, DOI 10.1111/jocd.70794): mislabelling of trial material.
  12. Types of dark circles — Huang YL et al., Int J Dermatol 2014;53(2):164. Classification of 65 people, mixed type 78%. (As cited in the site’s existing column)
  13. Not confirmed — in a PubMed search on 2026-11-02 (“polynucleotide periorbital OR infraorbital OR periocular OR crow’s feet”, “polynucleotide hyaluronic periocular randomized”), we did not find a clinical trial under the Rejuran Eye product name, a trial comparing it with regular Rejuran around the eyes, a comparative study measuring viscosity against clumping · show-through, or session comparisons and bruising · swelling frequencies for Rejuran Eye. Product concentration · additives were also not confirmed in published material.
  14. Medical advertising law — Korean Medical Service Act Article 56(2) (no treatment testimonials · comparison with other clinics · superlatives). This is why this column carries no reviews · before-and-after photos · prices.
  15. Miso Clinic clinical guidelines — treatment criteria carried over directly from Miso Clinic’s Rejuran page (/rejuran/) and existing columns (daegu-rejuran-types · daegu-rejuran-evidence · eye-skinbooster-choice · daegu-eye-booster-amount · daegu-under-eye-lines).

Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.

← Clinical columns · Reference library · Miso Clinic home

한국어 · English · 日本語